As a result, the combination of IFN-γ and β-glucan treatment of MPE-Mφ may re-educate MPE-Mφ to become the anti-tumor M1 type and the combination more responsible for Th1 subtype differentiation in the tumor microenvironment compared to either single treatment alone. The gene discussed is IFNG; the disease is neoplasm.